Last updated on April 18, 2014 at 11:57 EDT

Latest Transaction Nabi Stories

2012-08-16 02:25:09

NEW YORK, Aug. 16, 2012 /PRNewswire/ -- The Mangrove Partners Fund, L.P., one of Nabi Biopharmaceuticals' largest stockholders, today announced that it has delivered a letter to the stockholders of Nabi Biopharmaceuticals (Nasdaq: NABI). The full text of the letter follows: August 16, 2012 Dear Fellow Stockholders: Your support in voting against the proposed merger (the "Transaction") between Nabi Biopharmaceuticals ("Nabi" or the "Company") and Biota Holdings Limited, a...